Navigation Links
Immune-based drug approved in Europe for pediatric cancer patients
Date:3/10/2009

HOUSTON ? The European Commission, which oversees legislation and regulation for the European Union, has approved a therapy for pediatric patients with non-metastatic, resectable osteosarcoma, a type of bone cancer. The approval is based on clinical studies led by researchers at The University of Texas M. D. Anderson Cancer Center and a national co-operative group.

MEPACT (mifamurtide, L-MTP-PE) is an immune-based therapy, that when combined with chemotherapy, resulted in approximately a 30 percent decrease in the risk of death with 78 percent of patients surviving more than six years following treatment. This therapy is the first in more than 20 years to improve the long-term survival of osteosarcoma patients.

Eugenie Kleinerman, M.D., head of the Children's Cancer Hospital at M. D. Anderson Cancer Center, was the first investigator to translate the drug from preclinical testing to a Phase I clinical trial in humans. She also led the Phase II clinical trial for pediatric patients with relapsed osteosarcoma, which was followed by a Children's Oncology Group Phase III trial for newly diagnosed patients.

Kleinerman originally proposed the use of this immune therapy for osteosarcoma after Isaiah J. Fidler, D.V.M., Ph.D., professor in M. D. Anderson's Department of Cancer Biology and director of the Center for Metastasis Research, demonstrated that MEPACT induced the regression of melanoma lung metastases in mice.

"When he showed that MEPACT caused the macrophages in the lung to kill tumor cells, I decided that the drug may have therapeutic potential in patients with osteosarcoma, which most often metastasizes to the lungs," says Kleinerman. "From my own preclinical research, we were able to show how MEPACT stimulated human immune cells to react against osteosarcoma cells."

MEPACT works by stimulating certain white blood cells, called macrophages, to kill tumor cells. The drug is shaped in a sphere, also known as a v
'/>"/>

Contact: Sara Farris
sfarris@mdanderson.org
713-792-9133
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. $52.5 Million Settlement Against Sepracor Inc. Approved
2. FDA Cracks Down on Unapproved Cough Medicines
3. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
4. Optometry-Backed Vision Care for Kids Act Approved by U.S. House
5. Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
6. A fresh look at existing therapies: Researchers explore ways to teach approved drugs new tricks
7. Barrs Generic Version of Estrostep(R) Fe Tablets Approved
8. PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
9. Pennsylvania American Waters Rate Case Approved
10. RNs Statement on Death of Nataline Sarkisyan: CIGNA Should Have Listened to her Doctors and Approved the Transplant a Week Ago
11. Hiemstra Approved to Manufacture Medical Devices in New CER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... NEW ORLEANSA new three-drug combination has shown in a ... "highly effective regimen" in the treatment of patients newly ... cells in bone marrow, say researchers from Dana-Farber Cancer ... all of the 66 patients treated with the drug ... a "very good partial response rate" in the phase ...
(Date:12/5/2009)... WASHINGTON, Dec. 5 ,, What: Cuts ... a difference in the fight against cancer and other terminal ... will be donated to St. Jude Children,s Research Hospital. Guests ... Sisters, a delectable and savory Vietnamese restaurant in Falls Church ...
(Date:12/5/2009)... Type of Blood Cancer Is Most Challenging-- ... oncologists have identified specific genes, dubbed partner genes, that ... of leukemia in infants. By more accurately defining specific ... may benefit from particular treatments. ,, Oncologists also ...
(Date:12/5/2009)... to eliminate triggers, experts advise , , SATURDAY, Dec. 5 ... allergies and asthma can have bad reactions to certain ... prevent sneezing and wheezing, according to the American College ... are allergic to live evergreens may choose to decorate ...
(Date:12/5/2009)... their cleaning processes. The technology available to the lab allows it ... customers relating to cleaning parts, process development, and verification. , ... ... a Jackson, MI-based company, is home to an advanced technology center ...
Breaking Medicine News(10 mins):Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... a professor in Penn's Department of Psychology and researcher ... which reported that people couldn’t resist a pretty face. ... positive trait. Participants were given a fraction of a ... ,Participants took very little time in judging attractiveness knowing ...
... Department of Health Services would be banning Mexican candies with ... high levels of lead// in Mexican candies the Officials ... high amount of lead. It is known that there are ... Government is planning to have stringent quality check testing of ...
... Mumbai City has been providing mother's milk to newborn babies. ... to newborns and premature babies whose mothers do not lactate. ... of nutrients and is the most easily digestible food for ... systems, apart from other deficiencies. ,However, the ...
... are awaiting FDA approval and if approved could provide the ... drugs. These new drugs are to be reviewed by the ... sales drug.// Acomplia and Alli are the two new anti-obesity ... ,Acomplia is manufactured by Sanofi-Aventis and the drug acts by ...
... M. Murphy, M.D., and colleagues say that mutation in CCR5 ... the risk of developing West Nile virus (WNV) illness. // ... due to a mosquito-borne virus. This research as conducted at ... the results of the research appear in The Journal of ...
... financial crisis would put an end to the new scheme, which ... ,This scheme comes under the National Health Center (NHS). ... transferring the powers to the regional health bosses. ... by few of the hospitals that come under the NHS. ...
Other Medicine News:Health News:Are pretty faces associated with positive trait? 2Health News:Human Milk Center Caters To Premature Babies 2Health News:CCR5 Mutation Confers Immunity Against HIV But Not Against West Nile Virus Illness 2Health News:New UK Policy Threatens The Flexible Working Scheme 2
(Date:12/4/2009)... Dec. 4 The U.S. Food and ... form as an option for the treatment of schizophrenia ... disorder in adolescents aged 13-17 years old. ,, ... into consideration the increased potential for weight gain and ...
(Date:12/4/2009)... announced today that it received accreditation by the Accreditation ... services. For nearly 15 years, Amber Pharmacy has provided ... unique needs of specialized conditions. Amber Pharmacy is one ... They work with over 170 transplant programs and manage ...
(Date:12/4/2009)... Shared Imaging, LLC, an independent provider of ... for hospitals and healthcare providers, is excited to ... for Ambulatory Health Care, a nationally-recognized, prestigious gold ... patient care. Shared Imaging accreditation is system-wide for ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2CDPHP Honored for Best Disease Management Program in Upstate New York 58703 1CDPHP Honored for Best Disease Management Program in Upstate New York 58703 2CDPHP Honored for Best Disease Management Program in Upstate New York 58703 3Capital BlueCross Invites National Association Leader Karen Ignagni to Discuss Status of Health Care Reform 58701 1Capital BlueCross Invites National Association Leader Karen Ignagni to Discuss Status of Health Care Reform 58701 2Washington State Nurses Association Seeks Injunction in Federal Court to Block Mandatory Vaccination Policy by MultiCare Health System 58699 1Washington State Nurses Association Seeks Injunction in Federal Court to Block Mandatory Vaccination Policy by MultiCare Health System 58699 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: